ASH 2023

ASH 2023
December 09-12, 2023
San Diego, CA

American Society of Hematology.

Explore more information for Gilead Oncology therapies
Results (1)

Safety and Tolerability of Magrolimab Combinations in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Safety Run-in Results from a Phase 2 Study